The effect of prostaglandin E2 and calcium gluconate on orthodontic tooth movement and root resorption in rats.
Possible modifications in orthodontic tooth movement (OTM) and root resorption as a result of local injections of prostaglandin E2 (PGE2) alone and with calcium gluconate (Ca) formed the aim of the present study. Twenty-four 8-week-old male Wistar rats were selected and randomly divided into three groups of eight. Both quadrants of the upper jaws of the first group of animals were used; therefore this group comprised two groups: control and normal. The upper left first molars of these eight animals were not placed under orthodontic force and received no injection, to serve as the normal group, considered for root resorption comparison only. The control group had localized submucosal injections of normal saline on the buccal side of the upper right first molar. In the third group, 0.1 ml of 1 mg/ml PGE2 was injected at the same site and the fourth group received an intraperitoneal injection of 200 mg/kg Ca (10%) in addition to the PGE2. All the injections were performed on days 0 and 7. The orthodontic appliance consisted of a closed coil spring ligated to the upper right first molar and incisor, exerting a force of 60 g during the 21-day experimental period, after which the animals were sacrificed. Palatal halves were removed for histological examination and for calculation of the amount of root resorption. Statistical analysis of data showed a significant (P < 0.05) acceleration in OTM after PGE2 injection compared with the control group. The addition of Ca reduced OTM but a significant increase (P< 0.05) was still recorded. A significant difference (P < 0.05) in root resorption was only observed between the PGE2 and normal groups. The findings show the importance of calcium ions working in association with PGE2 in stabilizing root resorption while significantly increasing OTM.
Department of Orthodontics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Massoud
M
Seifi
Behnam
B
Eslami
Arash Shoja
AS
Saffar
D000704:Analysis of Variance; D000818:Animals; D002125:Calcium Gluconate / Q000008:administration & dosage / Q000627:therapeutic use*; D015232:Dinoprostone / Q000008:administration & dosage / Q000627:therapeutic use*; D007091:Image Processing, Computer-Assisted; D007267:Injections; D007274:Injections, Intraperitoneal; D008297:Male; D008437:Maxilla / Q000187:drug effects / Q000473:pathology; D008963:Molar / Q000187:drug effects*; D009969:Orthodontic Wires; D010159:Palate / Q000187:drug effects / Q000473:pathology; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012391:Root Resorption / Q000473:pathology / Q000517:prevention & control*; D018709:Statistics, Nonparametric; D013314:Stress, Mechanical; D013997:Time Factors; D014087:Tooth Movement Techniques / Q000295:instrumentation
D015232:Dinoprostone; D002125:Calcium Gluconate